Bildkälla: Stockfoto

Alligator Bioscience: Rights Issue and Henlius - Redeye

Redeye discusses Alligator Bioscience's rights issue announced on 2 January. It also provides a brief comment on the start of phase III for AC101.

Redeye discusses Alligator Bioscience's rights issue announced on 2 January. It also provides a brief comment on the start of phase III for AC101.
Börsvärldens nyhetsbrev
ANNONSER